Market value tracking: Matrix Pharmaceutical Inc. (MATX)

The chart shows the weekly change in the indexed market value of MATX (dotted line with triangles) compared to The Carson Life Sciences Index of 190 smaller cap companies (<$500M, solid line with squares). The initial index value is 100 as of Dec. 31, 1993. MATX, which last week said Accusite injectable gel to treat genital warts was recommended for a product license in the U.K., closed the week at $24.25, up $0.438 (see story below). It has a market cap of about $382 million.